GlassScriptPhysician profile
Ellen Oppenheimer
NPI 1841224680
$5,857.71
in general payments reported to CMS, 2019-2025
40 companies · $1,211 in 2025
The $1,211 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $774 · 2020: $547 · 2021: $624 · 2022: $665 · 2023: $1,001 · 2024: $1,037 · 2025: $1,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,248.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $767.94 | 2019-2025 | Sogroya, Norditropin, Wegovy |
| Abbvie INC. | $657.36 | 2019-2025 | |
| Pfizer INC. | $548.50 | 2019-2025 | |
| Insulet Corporation | $422.83 | 2019-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $351.11 | 2023-2025 | |
| Dexcom, INC. | $302.03 | 2019-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Alexion Pharmaceuticals, INC. | $263.38 | 2019-2024 | Strensiq |
| Lilly USA, LLC | $215.15 | 2020-2023 | Baqsimi |
| Tandem Diabetes Care, INC. | $190.02 | 2019-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Beta Bionics, INC. | $185.98 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Ascendis Pharma Endocrinology INC | $176.71 | 2022-2025 | Skytrofa |
| Endo Pharmaceuticals INC. | $169.76 | 2019-2024 | Supprelin |
| Ipsen Biopharmaceuticals, INC | $142.66 | 2019-2022 | |
| Abbott Laboratories | $141.45 | 2020-2023 | Freestyle Libre 3 |
| Tolmar, INC. | $100.21 | 2023-2025 | Fensolvi |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Oppenheimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.